Measuring protein fragments in spinal fluid may soon help doctors predict which patients with mild memory loss will go on to develop Alzheimer’s disease.

Patients with mild Alzheimer’s disease whose vision has improved after a cataract surgery may also experience a boost in behavioral problems.

A nursing home billed as Indiana’s first dedicated solely to patients with Alzheimer’s disease will have its grand opening this week in Indianapolis. Read more at www.WISHTV.com

A team of physicians and scientists from the University of California, San Diego School of Medicine and elsewhere describe using a combination of broadly available medical tests to produce a much improved predictive picture of the likelihood of impending AD in patients with mild cognitive impairment (MCI) - an intermediate stage between the expected cognitive decline of normal aging and the more …

( University of California - San Diego ) A team of physicians and scientists from the University of California, San Diego School of Medicine, and elsewhere describe using a combination of broadly available medical tests to produce a much improved predictive picture of the likelihood of impending AD in patients with mild cognitive impairment — an intermediate stage between the expected cognitive …

Alzheimer’s disease could be the result of an infection in some cases, researchers at the University of Texas Health Science Center have found.

For decades, doctors have diagnosed some patients with stroke and others with Alzheimer’s disease, even though the vast majority of seniors have a mix of both.

Washington, August 19 (ANI): Taking vitamin C might help patients with Alzheimer’s disease, a study has suggested.

Researchers in Chicago have paired up with a local theater group to see how improvisational theater games affect the health and mood of patients with early-stage Alzheimer’s disease.

Public Citizen has petitioned the FDA to ban high doses of the Alzheimer’s drug Aricept, claiming the risks far exceed the benefits. The drug, made by Pfizer and Elsai, has been approved at doses of 5 to 10 milligrams for patients with mild to moderate Alzheimer’s, and at 10 to 23 milligrams for those with more severe cases.

Two proteins that are abnormally modified in the brains of patients with Alzheimer’s disease collude, resulting in ill effects on the crucial energy centers of brain cells, according to new findings published online in Neurobiology of Aging.

A new blood test that will diagnose Alzheimer’s disease may soon hit the market, thanks to an innovative new study. The findings have characterized a unique biochemical diagnosis, which identifies patients with this devastating disorder.

A new research programme could lead to powerful new Alzheimer’s treatments within 10 years, it has been claimed.

( McGill University Health Centre ) A new blood test that will diagnose Alzheimer’s disease may soon hit the market, thanks to an innovative study from the Research Institute of the McGill University Health Centre. Their findings have characterized a unique biochemical diagnosis, which identifies patients with this devastating disorder.

A new analysis of key studies shows no benefit for the Alzheimer’s drug memantine in the treatment of patients with Alzheimer’s disease.

Memantine no better than a placebo for treating patients, U.S. meta-analysis shows

(Bloomberg) — Almost 15 million people care for U.S.

The blood of patients with the brain disease contains antibodies not found in healthy people.

TUESDAY, Nov. 2 (HealthDay News) — One of the main components of fish oil doesn’t help slow the development of symptoms in patients with early Alzheimer’s, although experts aren’t ruling out the possibility that supplementation given earlier might help prevent the disease.

Tens of thousands of extra Alzheimer’s sufferers will be given medicines on the NHS after a decision by the drugs rationing body to extend their use to patients with mild symptoms.